Key result
Personalized medicine, driven by advances in cardiac imaging and genetics, is transforming the diagnosis, risk stratification, and management of cardiomyopathies.
Answers are grounded in this paper and cite their sources.
This editorial introduces a special edition focusing on personalized medicine and various etiologies of cardiomyopathies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ávila et al. (2023) conducted an editorial in Cardiomyopathies. Personalized medicine was evaluated. Personalized medicine, driven by advances in cardiac imaging and genetics, is transforming the diagnosis, risk stratification, and management of cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: